You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company's goal is to serve what it sees as a massive but underaddressed target group: Asian women.
At Belgium's VIB, researchers have designed custom panels with CNV detection in mind to get better data on single-cell genomic changes during cancer treatment.
The San Diego-based firm has developed a new extracellular RNA sequencing method that it believes could be used for cancer diagnostics.
The company believes that Xdrop will find adopters in academia and clinical research, although diagnostics is on its radar.
The German company's new Genome Enhancer product is an adaptation of its flagship multi-omics software for clinicians and biologists without bioinformatics expertise.
Illumina plans to upgrade all its NIPT customers to version 2 of its VeriSeq solution over the next year.
The firm said it is helping customers convert from SNP genotyping arrays to an NGS workflow, which may allow it to access the ag-bio and direct-to-consumer markets.
The company is hoping to add outreach to make sure individuals who want counseling get it, and to better understand the reasons why others might not.
A collaboration with ATAC-seq experts at the Broad Institute suggests the Bio-Rad assay can analyze tens of thousands of cells per experiment.
New instrument releases at this week's meeting reflected proteomics' increased emphasis on throughput and the continuing spread of ion mobility technology.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.